Empagliflozin Targets NF-κB Signaling Through PTGS2 and TLR4 in Polycystic Ovary Syndrome: A Drug Repurposing Study and Molecular Simulation.

Nugraha IC, Febriza A, Tajuddin A, As'ad S

Open source

DOI
10.3390/jox16050169
Published
2026 Sep 7
Container
Journal of xenobiotics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jox16050169,
  title = {Empagliflozin Targets NF-κB Signaling Through PTGS2 and TLR4 in Polycystic Ovary Syndrome: A Drug Repurposing Study and Molecular Simulation.},
  author = {Nugraha IC and Febriza A and Tajuddin A and As'ad S},
  year = {2026},
  journal = {Journal of xenobiotics},
  doi = {10.3390/jox16050169},
  url = {https://doi.org/10.3390/jox16050169}
}

RIS

TY  - JOUR
TI  - Empagliflozin Targets NF-κB Signaling Through PTGS2 and TLR4 in Polycystic Ovary Syndrome: A Drug Repurposing Study and Molecular Simulation.
AU  - Nugraha IC
AU  - Febriza A
AU  - Tajuddin A
AU  - As'ad S
PY  - 2026
JO  - Journal of xenobiotics
DO  - 10.3390/jox16050169
UR  - https://doi.org/10.3390/jox16050169
ER  - 

APA

IC, N., A, F., A, T., & S, A. (2026). Empagliflozin Targets NF-κB Signaling Through PTGS2 and TLR4 in Polycystic Ovary Syndrome: A Drug Repurposing Study and Molecular Simulation.. Journal of xenobiotics. https://doi.org/10.3390/jox16050169

Source records